Abstract
Recent advances in real-time magnetic resonance imaging (rtMRI) of the vocal tract provides opportunities for studying human speech. This modality together with acquired speech may enable the mapping of articulatory configurations to acoustic features. In this study, we take the first step by training a deep learning model to classify 27 different phonemes from midsagittal MR images of the vocal tract.An American English database was used to train a convolutional neural network for classifying vowels (13 classes), consonants (14 classes) and all phonemes (27 classes) of 17 subjects. Classification top-1 accuracy of the test set for all phonemes was 57%. Erroranalysis showedvoiced and unvoiced sounds often being confused. Moreover, we performed principal component analysis on the network’s embedding and observed topological similarities between thenetwork learned representation and the vowel diagram.Saliency maps gaveinsight intothe anatomical regions most important for classification and show congruence with knownregions of articulatory importance.We demonstrate the feasibility for deep learning to distinguish between phonemes from MRI. Network analysis can be used to improve understanding of normal articulation and speech and, in the future, impaired speech. This study brings us a step closer to the articulatory-to-acoustic mapping from rtMRI.
Original language | English |
---|---|
Pages (from-to) | 909-913 |
Number of pages | 5 |
Journal | Interspeech |
Volume | 20 |
DOIs | |
Publication status | Published - 2019 |
Event | Interspeech 2019 - Graz, Austria Duration: 15 Sept 2019 → 19 Dec 2019 |
Bibliographical note
Crossroads of speech and language : 20th Annual Conference of the International Speech Communication Association : INTERSPEECH 2019 : Graz, Austria, 15-19 September 2019Funding
The Department of Head and Neck Oncology and surgery of the Netherlands Cancer Institute receives a research grant from Atos Medical AB (Malmö, Sweden), which contributes to the existing infrastructure for quality of life research.
Funders | Funder number |
---|---|
Atos Medical AB | |
Netherlands Cancer Institute |